| The complexity of management of pregnancy-associated malignant soft tissue and bone tumors. | |
| | |
MedLine Citation:
|
PMID: 17878735 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The incidence of musculoskeletal tumors during pregnancy is very low. The aim of this study was to summarize our experience in treating a large cohort of pregnant patients diagnosed with these rare tumors. METHODS: Women diagnosed with musculoskeletal tumors during pregnancy or immediately after delivery were identified retrospectively in our database between 1996 and 2006. Relevant maternal and neonatal data were collected. RESULTS: Twenty patients, 8 with bone sarcomas (BS) and 12 with soft tissue sarcomas (STS) were identified. Two women were treated by wide excision of mass during pregnancy. In all other cases oncological treatment was delayed until delivery or termination of pregnancy. Vaginal delivery was possible in 9 patients, cesarean section was performed in 7, spontaneous abortion occurred in 1, and 3 underwent termination of pregnancy. Three newborns were premature, but normal growth and development were observed. Different techniques of fertility preservation were used in our patients. Five patients with BS and 5 patients with STS received preoperative chemotherapy, with different grades of toxicity. The degree of tumor necrosis tended to correlate with dose-intensity of chemotherapy. Seven patients with BS received adjuvant chemotherapy. Two patients with STS received adjuvant chemotherapy, two - radiotherapy, and four - both modalities. Median disease-free survival was 15.1 months, median overall survival - 25.4 months. CONCLUSIONS: Musculoskeletal tumors diagnosed during pregnancy, or after delivery, do not appear to have a significant impact on the prognosis. A multidisciplinary team should tailor the oncological approach individually. |
| | |
Authors:
|
Rinat Bernstein Molho; Yehuda Kollender; Josephine Issakov; Jacob Bickels; Gideon Flusser; Fuad Azem; Adele Alon; Moshe J Inbar; Isaac Meller; Ofer Merimsky |
Related Documents
:
|
22758775 - Lymph node density for patient counselling about prognosis and for designing clinical t... 8088765 - Histopathological classification of childhood rhabdomyosarcomas: relationship with clin... 22834655 - Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab tre... 22825265 - Platinum-based combination chemotherapy for the treatment of advanced-stage squamous ce... 8347255 - Comparison of dna content in primary and lymph node metastases in prostate adenocarcinoma. 15043345 - Anorectal melanoma: report of three cases with extended follow-up. |
Publication Detail:
|
Type: Journal Article Date: 2007-09-18 |
Journal Detail:
|
Title: Gynecologic and obstetric investigation Volume: 65 ISSN: 1423-002X ISO Abbreviation: Gynecol. Obstet. Invest. Publication Date: 2008 |
Date Detail:
|
Created Date: 2008-03-05 Completed Date: 2008-04-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7900587 Medline TA: Gynecol Obstet Invest Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 89-95 Citation Subset: IM |
Copyright Information:
|
(c) 2008 S. Karger AG, Basel. |
Affiliation:
|
Unit of Bone and Soft Tissue Oncology, Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortion, Induced Adult Bone Neoplasms / complications, mortality, therapy* Cohort Studies Combined Modality Therapy Delivery, Obstetric* Disease-Free Survival Female Humans Pregnancy Pregnancy Complications, Neoplastic / mortality, therapy* Pregnancy Outcome Prognosis Retrospective Studies Sarcoma / complications, mortality, therapy* Soft Tissue Neoplasms / complications, mortality, therapy* Survival |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assessment of fetomaternal hemorrhage by flow cytometry and Kleihauer-Betke test in Rh-negative preg...
Next Document: Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.